635
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older

, , , , , , , , & show all
Pages 1079-1090 | Received 17 Jun 2023, Accepted 19 Oct 2023, Published online: 08 Nov 2023